Dear Colleague
The first update of concessionary prices were granted today for August 2025:
DrugPack SizeConcessionary Price
Alfuzosin 2.5mg tablets60£7.22
Clarithromycin 250mg/5ml oral suspension70£10.52
Cyclizine 50mg/1ml solution for injection ampoules5£4.01
Dutasteride 500microgram capsules30£2.88
Ibuprofen 600mg tablets84£9.38
Imipramine 25mg tablets28£2.73
Isosorbide mononitrate 10mg tablets56£1.75
Mometasone 0.1% cream100£12.21
Mometasone 0.1% cream30£4.12
Mometasone 0.1% ointment30£4.08
Oxybutynin 2.5mg tablets56£1.55
Oxybutynin 5mg tablets56£3.67
Pioglitazone 15mg tablets28£6.49
Pramipexole 88microgram tablets30£3.93
Progesterone micronised 100mg capsules30£4.86
Risperidone 500microgram orodispersible tablets sugar free28£6.17
Sitagliptin 100mg tablets28£6.32
Sitagliptin 25mg tablets28£2.49
Sitagliptin 50mg tablets28£3.63
Sodium bicarbonate 500mg capsules56£7.16
Trimethoprim 50mg/5ml oral suspension sugar free100£5.32
Ursodeoxycholic acid 150mg tablets60£72.11

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
REMINDER: LIVING WELL CAMPAIGN SURVEY
** FAO LIVING WELL PHARMACIES ONLY **
Dear Contractor
Correspondence has been issued by SPPG on 18 August 2025 to those pharmacies yet to submit an evaluation survey for the Living Well campaign 
Know your units‘.

SUMMARY

  • All pharmacies contracted to provide the Living Well service must complete an evaluation survey after each campaign, unless otherwise informed.
  • SPPG reserves the right to recoup payment for a campaign if the evaluation survey is not submitted.
  • The survey for the campaign ‘Know your units’ is open and can be accessed here.
  • The survey must be completed by 6pm Monday 1st September 2025, please ensure to reach the final screen to confirm submission.

ACTION

  • Contractors who have yet to complete the Living Well survey for the campaign ‘Know your units’ are asked to read the correspondence issued by SPPG on 18 August 2025 and share with relevant team members.

For any further information please contact CPNI offices.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

BSO ALERTS

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Contractor
NICPLD issued correspondence on 6 August 2025 seeking expressions of interest from pharmacists to join a newly formed FTY Stakeholder Committee.

SUMMARY

  • Information on the role of the FTY Stakeholder Committee and the criteria for membership is included in the NICPLD correspondence.
  • NICPLD has advised that the expression of interest form will now remain open until 12 noon,  Wednesday 20 August 2025
  • NICPLD has received a number of responses to date and would particularly encourage pharmacists from independent pharmacy FTY providers to come forward to ensure balanced representation.

ACTION

  • Contractors should read the NICPLD correspondence and share with relevant members of the pharmacy team.
  • Queries regarding FTY or the Stakeholder Committee can be directed to NICPLD.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Living Well Social Media Schedule

The social media schedule for the new Living Well campaign – ‘Move more, feel better’ is available here.

This campaign runs from 1st August – 30th September 2025 and community pharmacies may wish to share the campaign messages on their social media platforms.

NICPLD FTY Stakeholder Committee

NICPLD is seeking expressions of interest from pharmacists to join a newly established FTY Stakeholder Committee.  The committee will support NICPLD in the quality management of the FTY programme, including review of policies and procedures, and ensuring the programme continues to meet the Standards for the initial education and training of pharmacists (2021).  NICPD is seeking representatives from community pharmacy FTY providers to join the committee, as well as early career pharmacists, educational supervisors (ES) and designated prescribing practitioners (DPP).

Further information is available here, and those who would like to express an interest are asked to complete the online form by no later than Wednesday 13th August at 12 noon.

Fully Funded Training for Community Pharmacy Support Staff

Horizon Global Skills has advised CPNI that they are seeking applications for an upcoming fully funded Pharmacy Services Upskilling Academy.  The course will commence in September 2025 and successful participants will be awarded a Level 2 Diploma in the Principles and Practise for Pharmacy Support Staff.  The costs of the training will be funded via a Department for Economy initiative, and employers will receive £558 for each employee who successfully completes the training.

A brochure with further details is available here.  And further information can be obtained by emailing catherine@ghskills.com.

Research Participation

CPNI has been contacted by a team in Robert Gordon University regarding research they are undertaking on how pharmacy services can better support people before pregnancy (preconception care).  They are inviting pharmacy team members to participate in a Patient and Public Involvement (PPI) panel.

The PPI panel will be informal, flexible, and online, with no prior research experience required.  Further information is available here, and those who wish to participate can sign up here.

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Colleague
The Department of Health and Social Care (DHSC) has redetermined the following July 2025 concessionary prices:
DrugPack
Size
Concessionary Price
Fexofenadine 180mg tablets30£4.10 (previously £2.31)
Pioglitazone 45mg tablets28£26.10 (previously £25.25)
Trihexyphenidyl 2mg tablets 84£61.43 (previously £38.31)

These improved prices will apply to prescriptions submitted for payment for the dispensing month of July 2025.

Please note that these revised prices do not apply to August 2025 prescriptions.

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive